Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation

BACKGROUND: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) followed by upfront autologous st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Res
Main Authors: Lee, Hong Ghi, Kim, Sung-Yong, Kim, Inho, Kim, Yeo-Kyeoung, Kim, Jeong-A, Kim, Yang Soo, Lee, Ho Sup, Park, Jinny, Kim, Seok Jin, Shim, Hyeok, Eom, Hyeon Seok, Park, Byeong-Bae, Lee, Junglim, Park, Sung Kyu, Cheong, June-Won, Park, Keon Woo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595582/
https://ncbi.nlm.nih.gov/pubmed/26457283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.3.160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados